Laboratorios Farmaceuticos Rovi, S.A. - Special Call Transcript
Good morning, ladies and gentlemen. Thank you for standing by. Welcome to today's positive top line results from Phase III Study of Doria Conference Call. (Operator Instructions)
I must advise you that this conference is being recorded today, the 19th March, 2019.
I would like to hand the conference over to your speaker today, Juan López-Belmonte. Please go ahead.
Thank you, very much, and good morning to everyone. This is Javier López-Belmonte, CFO of ROVI. At this time, I would like to welcome everybody to this conference call to discuss Doria positive topline results, which will start in a moment. Let me please first introduce ROVI's attendees today. Juan López-Belmonte, CEO; Ibón Gutierro, Corporate R&D Director; Marta Campos, Investor Relations, and myself.
All lines are now mute to prevent any background noise. After the presentation, as the operator said, there will be a question-and-answer session.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |